Cargando…
Epidermolysis Bullosa Acquisita: The 2019 Update
Epidermolysis bullosa acquisita (EBA) is an orphan autoimmune disease. Patients with EBA suffer from chronic inflammation as well as blistering and scarring of the skin and mucous membranes. Current treatment options rely on non-specific immunosuppression, which in many cases, does not lead to a rem...
Autores principales: | Koga, Hiroshi, Prost-Squarcioni, Catherine, Iwata, Hiroaki, Jonkman, Marcel F., Ludwig, Ralf J., Bieber, Katja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6335340/ https://www.ncbi.nlm.nih.gov/pubmed/30687710 http://dx.doi.org/10.3389/fmed.2018.00362 |
Ejemplares similares
-
Meta-analysis of the clinical and immunopathological characteristics and treatment outcomes in epidermolysis bullosa acquisita patients
por: Iwata, Hiroaki, et al.
Publicado: (2018) -
Epidermolysis bullosa acquisita()
por: Miyamoto, Denise, et al.
Publicado: (2022) -
Therapeutic Effect of a Novel Phosphatidylinositol-3-Kinase δ Inhibitor in Experimental Epidermolysis Bullosa Acquisita
por: Koga, Hiroshi, et al.
Publicado: (2018) -
Pathological Relevance of Anti-Hsp70 IgG Autoantibodies in Epidermolysis Bullosa Acquisita
por: Tukaj, Stefan, et al.
Publicado: (2022) -
Clinical Presentation, Pathogenesis, Diagnosis, and Treatment of Epidermolysis Bullosa Acquisita
por: Ludwig, Ralf J.
Publicado: (2013)